Registry of Lobbyists

Advanced Registry Search Results

Search Criteria

  1. DPOH name: SKENE, JEFFREY
Share this search Create an alert

Refine registrations results by

Refine monthly communication reports results by

Type Subject matter of the communication
Government institution of the DPOH

If you would like to view a summary of the last 12 months for a lobbying activity, use the 12-Month Lobbying Activity Search

Monthly communication reports (4)
Results: 1-4 | Export
  1. Cystic Fibrosis Canada / Fibrose kystique Canada
    Type: In-house Organization
    Occurred: 2024-02-05
    Posted: 2024-02-15
    Designated public office holders:
    • Jeffrey Skene, Director, Health Products and Food Branch, Pharmaceutical Drugs Directorate, Bureau of Cardiology, Allergy and Neurological Sciences | Health Canada (HC)
    • Karen Reynolds, Director General, Pharmaceutical Drugs Directorate, Health Products and Food Branch | Health Canada (HC)
    • Julie Dabrusin, Member of Parliament | House of Commons
    • Dan Albas, Member of Parliament | House of Commons
    • Andrew Taylor, Director, Policy, Research, and Data, Strategic Policy Branch, Office of Pharmaceuticals Management Strategies | Health Canada (HC)
    Subject matters:
    • Health
  2. Canadian Biosimilars Forum / Forum canadien des biosimilaires
    Type: Consultant
    Lobbyist: Ross Wallace, Santis Health
    Occurred: 2017-11-21
    Posted: 2018-01-17
    Designated public office holders:
    • Laura Johnson, SBD Project Manager, THERAPEUTIC PRODUCTS DIRECTORATE | Health Canada (HC)
    • Sandra Alderdice, Regulatory Affairs Supervisor, BIOLOGICS AND GENETIC THERAPIES DIRECTORATE | Health Canada (HC)
    • Andrea Bedard, Policy Analyst, BIOLOGICS AND GENETIC THERAPIES DIRECTORATE | Health Canada (HC)
    • Liz Anne Gillham-Eiosen, A Director, BIOLOGICS AND GENETIC THERAPIES DIRECTORATE | Health Canada (HC)
    • Cathy Parker, Director General, BIOLOGICS AND GENETIC THERAPIES DIRECTORATE | Health Canada (HC)
    • Georgette Roy, Director, BIOLOGICS AND GENETIC THERAPIES DIRECTORATE | Health Canada (HC)
    • Agnes Klein, Senior Medical Advisor, DGO, BIOLOGICS AND GENETIC THERAPIES DIRECTORATE | Health Canada (HC)
    • Jian Wang, Division Chief, BIOLOGICS AND GENETIC THERAPIES DIRECTORATE | Health Canada (HC)
    • Stephanie Hardy, Manager, Policy Unit, BIOLOGICS AND GENETIC THERAPIES DIRECTORATE | Health Canada (HC)
    • Anthony Ridgway, Acting Director, BIOLOGICS AND GENETIC THERAPIES DIRECTORATE | Health Canada (HC)
    • Jeffrey Skene, Division Chief, BIOLOGICS AND GENETIC THERAPIES DIRECTORATE | Health Canada (HC)
    • Alain Musende, Manager, MARKETED HEALTH PRODUCTS DIRECTORATE | Health Canada (HC)
    • Michele Chadwick, Manager, BIOLOGICS AND GENETIC THERAPIES DIRECTORATE | Health Canada (HC)
    • Parag Buch, Subject Matter Technical Special, MARKETED HEALTH PRODUCTS DIRECTORATE | Health Canada (HC)
    • Wallace Lauzon, Division Chief, BIOLOGICS AND GENETIC THERAPIES DIRECTORATE | Health Canada (HC)
    Subject matters:
    • Health
  3. Canadian Biosimilars Forum / Forum canadien des biosimilaires
    Type: Consultant
    Lobbyist: Ross Wallace, Santis Health
    Occurred: 2017-06-09
    Posted: 2017-08-04
    Designated public office holders:
    • Nick Orphanos, Senior Policy Analyst, Health Products and Food Branch | Health Canada (HC)
    • Stephanie Hardy, Manager, Policy Unit, Health Products and Food Branch | Health Canada (HC)
    • Deryck Trehearne, Director General, Health Products and Food Branch | Health Canada (HC)
    • Wallace Lauzon, Division Chief, Health Products and Food Branch | Health Canada (HC)
    • Agnes Klein, Senior Medical Advisor, Health Products and Food Branch | Health Canada (HC)
    • Cathy Parker, Director General, Health Products and Food Branch | Health Canada (HC)
    • Georgette Roy, Director, Office of Regulatory Affairs, Health Products and Food Branch | Health Canada (HC)
    • Trish Larwill, Senior Policy Advisor, Health Products and Food Branch | Health Canada (HC)
    • Jian Wang, Division Chief, Health Products and Food Branch | Health Canada (HC)
    • Michele Chadwick, Manager, Health Products and Food Branch | Health Canada (HC)
    • Catherine Njue, Biostatistician Advisor - Clinical Trials, Health Products and Food Branch | Health Canada (HC)
    • Liz Anne Gillham-Eisen, A/Director, Health Products and Food Branch | Health Canada (HC)
    • Emily Griffiths, Policy Analyst, Health Products and Food Branch | Health Canada (HC)
    • Anthony Ridgway, Acting Director, Health Products and Food Branch | Health Canada (HC)
    • Ashley Baer, Policy Analyst, Health Products and Food Branch | Health Canada (HC)
    • Jeffrey Skene, Division Chief, Health Products and Food Branch | Health Canada (HC)
    • Sandra Alderdice, Regulatory Affairs Supervisor, Health Products and Food Branch | Health Canada (HC)
    • Laura Johnson, SBD Project Manager, Health Products and Food Branch | Health Canada (HC)
    Subject matters:
    • Health
  4. Canadian Biosimilars Forum / Forum canadien des biosimilaires
    Type: Consultant
    Lobbyist: Ross Wallace, Santis Health
    Occurred: 2016-11-22
    Posted: 2016-12-15
    Designated public office holders:
    • Jian Wang, Division Chief, Health Products and Food Branch | Health Canada (HC)
    • Catherine Njue, Biostatistician Advisor - Clinical Trials, Health Products and Food Branch | Health Canada (HC)
    • Anthony Ridgway, Acting Director, Health Products and Food Branch | Health Canada (HC)
    • Andrea Bedard, Policy Analyst, Health Products and Food Branch | Health Canada (HC)
    • Wallace Lauzon, Division Chief, Health Products and Food Branch | Health Canada (HC)
    • Stephanie Hardy, Manager, Policy Unit, Health Products and Food Branch | Health Canada (HC)
    • Georgette Roy, Director, Office of Regulatory Affairs, Health Products and Food Branch | Health Canada (HC)
    • Bobby Chauhan, Senior Regulatory Officer, Health Products and Food Branch | Health Canada (HC)
    • Agnes Klein, Director, Health Products and Food Branch | Health Canada (HC)
    • Jeffrey Skene, Division Chief, Health Products and Food Branch | Health Canada (HC)
    • Catherine Parker, Director General, Health Products and Food Branch | Health Canada (HC)
    • Sandra Alderdice, Regulatory Affairs Supervisor, Health Products and Food Branch | Health Canada (HC)
    • Liz Anne Gillham-Eisen, A/Director, Health Products and Food Branch | Health Canada (HC)
    Subject matters:
    • Health

Date Modified: